Treating the male sexual partners of women with bacterial vaginosis significantly reduced recurrence, according to an Australian randomized controlled trial that was stopped early for efficacy. Only 35% of women who were treated for bacterial vaginosis along with their male sexual partners had recurrence in the study period compared with 63% of women who received treatment alone (recurrence rate 1.

Bacterial vaginosis is a poorly understood infection that affects one in three women and can bring with it uncomfortable symptoms and, sometimes, long-term health complications. Treatment is often unsuccessful, with 60 percent of B.V. cases recurring within a year, keeping women stuck in a disruptive cycle of going on and off antibiotics.

Bacterial vaginosis affects nearly 1 in 3 women of reproductive age. A study adds to evidence it is sexually transmitted, offering a new way to reduce recurrence.

The results of a randomized controlled trial conducted in Australia indicate that the addition of antibiotic treatment for male partners of women who have bacterial vaginosis (BV) significantly reduces recurrence of the infection, researchers reported yesterday in the New England Journal of Medicine.

Researchers have shown far better cure rates for bacterial vaginosis when the condition is treated as a sexually transmitted infection.

Bacterial vaginosis affects one in three women and often comes back after treatment, but it can be completely wiped out in most cases if their male partner is treated too.

Bacterial vaginosis, which is caused by bacteria overgrowing in the vagina, can be hard to treat, with women often experiencing recurring symptoms. Now it seems that asking their male sexual partners

A trial with a new approach to treating bacterial vaginosis (BV), a condition that affects millions of people across the globe, has suggested that treating both affected females and their male partners with antibiotics can significantly reduce the risk of their symptoms returning.